SPINEGUARD overview

Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announces its full-year 2024 financial results for the year ended December 31, 2024, as approved by the Board of Directors on April 15, 2025, and its first quarter 2025 sales. 2024 Financial Results In € thousands – IFRS audited 2024 2023 Revenue 4,648 4,313 Gross margin 3,628 3,379 Gross...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, today announced the signature of a binding term sheet for the transfer of the US subsidiary of SpineGuard. SpineGuard and Omnia Medical entered into collaboration in 2020 with as a US...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that its commercial partner Omnia Medical launched their codeveloped product PsiFGuard in the USA during the NANS (North American Neuromodulation Society) convention in Orlando, Florida (USA) from January 30 th to February 1 st , 2025. Stéphane Bette, Deputy...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG ® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today reports its full-year 2024 revenue. Pierre Jérôme, Chairman, CEO and co-founder of SpineGuard, said: "After a particularly challenging 2023 due to the termination of two important commercial agreements, SpineGuard is back to growth in 2024 particularly in the United...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, announces the completion of a bond financing agreement of an amount up to €1 million and the subscription of 100.000 euros to support the commercialization of its two new products featuring DSG® technology: Threaded PediGuard for anterior approach and PsiFGuard for...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG ® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, announced today the strengthening of their strategic partnership with the signing of a new agreement establishing the foundation for an expansion of their collaboration to other products and...

Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, announced today its schedule for the publication of financial information for 2025. 2025 financial calendar Event Date* 2024 Full-Year Sales January 10, 2025 2024 Full-Year Results April 15, 2025 2025 First-Quarter Sales April 15, 2025 Annual Shareholders Meeting June 11, 2025...